Kinnari Patel

This profile gathers the share dealings of Kinnari Patel in Rocket Pharmaceuticals, Inc. Over a trading history stretching from 6 December 2018 to 20 May 2025, the count stands at 30 filings.

The open-market side counts 3 purchases for €174k alongside 11 sales for €1.3M. The net balance comes to €1.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants and 11 option exercises. In 2025 alone, the filings show 1 purchase and 3 sales.

In size, the median ticket on the buying side is €75k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 22 May 2025 came the latest disclosure, an open-market sale for €4,380 in Rocket Pharmaceuticals, Inc. The most recent open-market purchase was published on 10 April 2025, 578 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.